Matches in Nanopublications for { ?s ?p "[This study reveals a novel mechanism of immune suppression sensitive to BRAF(V600E) inhibition, and indicates that clinical blockade of IL-1 may benefit patients with BRAF wild-type tumors and potentially synergize with immunotherapeutic interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP242415.RAS6S3nK6uKXqI4AZe7RgAIhO51eKEk2DqyfO4yz9F4MI130_assertion description "[This study reveals a novel mechanism of immune suppression sensitive to BRAF(V600E) inhibition, and indicates that clinical blockade of IL-1 may benefit patients with BRAF wild-type tumors and potentially synergize with immunotherapeutic interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP242415.RAS6S3nK6uKXqI4AZe7RgAIhO51eKEk2DqyfO4yz9F4MI130_provenance.
- NP505491.RASPb1Buzf64WMwNmZA5oI7HlExyURpZWhxh086VAUxt4130_assertion description "[This study reveals a novel mechanism of immune suppression sensitive to BRAF(V600E) inhibition, and indicates that clinical blockade of IL-1 may benefit patients with BRAF wild-type tumors and potentially synergize with immunotherapeutic interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505491.RASPb1Buzf64WMwNmZA5oI7HlExyURpZWhxh086VAUxt4130_provenance.
- assertion description "[This study reveals a novel mechanism of immune suppression sensitive to BRAF(V600E) inhibition, and indicates that clinical blockade of IL-1 may benefit patients with BRAF wild-type tumors and potentially synergize with immunotherapeutic interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This study reveals a novel mechanism of immune suppression sensitive to BRAF(V600E) inhibition, and indicates that clinical blockade of IL-1 may benefit patients with BRAF wild-type tumors and potentially synergize with immunotherapeutic interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This study reveals a novel mechanism of immune suppression sensitive to BRAF(V600E) inhibition, and indicates that clinical blockade of IL-1 may benefit patients with BRAF wild-type tumors and potentially synergize with immunotherapeutic interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP928718.RAMc5dzJAqGTut7DexWWmcnTgirfPWz0AKGsApZi0I58k130_assertion description "[This study reveals a novel mechanism of immune suppression sensitive to BRAF(V600E) inhibition, and indicates that clinical blockade of IL-1 may benefit patients with BRAF wild-type tumors and potentially synergize with immunotherapeutic interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP928718.RAMc5dzJAqGTut7DexWWmcnTgirfPWz0AKGsApZi0I58k130_provenance.
- NP1001885.RAd-8sxODv1oC5KX6Z0lk_rU-Pti5tmERH1akOGbM_qWE130_assertion description "[This study reveals a novel mechanism of immune suppression sensitive to BRAF(V600E) inhibition, and indicates that clinical blockade of IL-1 may benefit patients with BRAF wild-type tumors and potentially synergize with immunotherapeutic interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001885.RAd-8sxODv1oC5KX6Z0lk_rU-Pti5tmERH1akOGbM_qWE130_provenance.
- NP272860.RAB1Zr4vLJURZ5JZ4y8BcKQhtCBcq8sHi6xOPCD7lSjQg130_assertion description "[This study reveals a novel mechanism of immune suppression sensitive to BRAF(V600E) inhibition, and indicates that clinical blockade of IL-1 may benefit patients with BRAF wild-type tumors and potentially synergize with immunotherapeutic interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272860.RAB1Zr4vLJURZ5JZ4y8BcKQhtCBcq8sHi6xOPCD7lSjQg130_provenance.
- NP490658.RAx1-3pZtqjbJ5dnS0DNVqFhTrAVDnyYlmqzkWxeqcrpI130_assertion description "[This study reveals a novel mechanism of immune suppression sensitive to BRAF(V600E) inhibition, and indicates that clinical blockade of IL-1 may benefit patients with BRAF wild-type tumors and potentially synergize with immunotherapeutic interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP490658.RAx1-3pZtqjbJ5dnS0DNVqFhTrAVDnyYlmqzkWxeqcrpI130_provenance.
- NP488528.RAGIxwW0TwdEYsN8fjz2C37J4EF9Wjz70FOjXpX4WlRAg130_assertion description "[This study reveals a novel mechanism of immune suppression sensitive to BRAF(V600E) inhibition, and indicates that clinical blockade of IL-1 may benefit patients with BRAF wild-type tumors and potentially synergize with immunotherapeutic interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP488528.RAGIxwW0TwdEYsN8fjz2C37J4EF9Wjz70FOjXpX4WlRAg130_provenance.
- NP1001887.RA3ayuBJzqeCfvQOnZZ8yCZ8K1WqQx190weC--xQB8kTI130_assertion description "[This study reveals a novel mechanism of immune suppression sensitive to BRAF(V600E) inhibition, and indicates that clinical blockade of IL-1 may benefit patients with BRAF wild-type tumors and potentially synergize with immunotherapeutic interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001887.RA3ayuBJzqeCfvQOnZZ8yCZ8K1WqQx190weC--xQB8kTI130_provenance.
- NP1001894.RAxltXP0teCCcG9bmpOhRYfrEAjioc2nO_K3LCcAFOY8Y130_assertion description "[This study reveals a novel mechanism of immune suppression sensitive to BRAF(V600E) inhibition, and indicates that clinical blockade of IL-1 may benefit patients with BRAF wild-type tumors and potentially synergize with immunotherapeutic interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001894.RAxltXP0teCCcG9bmpOhRYfrEAjioc2nO_K3LCcAFOY8Y130_provenance.